Skip to search.
 FTSE 100 Down 0.54%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
406.36 29 Sep 21:00
|Pre-Market : 398.00 Down 8.36 (2.06%) 14:26 - Nasdaq Real Time Price
Prev Close:406.36
Open:N/A
Bid:398.01 x 100
Ask:399.99 x 100
1y Target Est:467.86
Beta:1.39963
Earnings Date:2 Nov - 7 Nov (Est.)
Day's Range:N/A - N/A
52wk Range:329.09 - 592.59
Volume:1,455
Avg Vol (3m):759,625
Market Cap:43.61b
P/E (ttm):63.39
EPS (ttm):6.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGN 0.00%43.61b
AMGN123.82b

Key Statistics

Forward P/E (1 yr):27.99
P/S (ttm):9.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :11.00
Quarterly EPS Est (Sep-16) :2.73
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback